337 related articles for article (PubMed ID: 19436661)
1. Amlodipine and valsartan as components of a rational and effective fixed-dose combination.
Waeber B; Ruilope LM
Vasc Health Risk Manag; 2009; 5(1):165-74. PubMed ID: 19436661
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.
da Silva PM
Clin Drug Investig; 2010; 30(9):625-41. PubMed ID: 20626210
[TBL] [Abstract][Full Text] [Related]
3. Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
Zappe D; Papst CC; Ferber P;
Vasc Health Risk Manag; 2009; 5():883-92. PubMed ID: 19898644
[TBL] [Abstract][Full Text] [Related]
4. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
5. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
[TBL] [Abstract][Full Text] [Related]
6. Amlodipine/Valsartan: fixed-dose combination in hypertension.
Plosker GL; Robinson DM
Drugs; 2008; 68(3):373-81. PubMed ID: 18257612
[TBL] [Abstract][Full Text] [Related]
7. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
Frampton JE; Scott LJ
Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
[TBL] [Abstract][Full Text] [Related]
8. Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination.
Trenkwalder P; Schaetzl R; Borbas E; Handrock R; Klebs S
Blood Press Suppl; 2008 Dec; 2():13-21. PubMed ID: 19205092
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of angiotensin II type 1 receptor blocker/calcium channel blocker combination therapy for hypertension: focus on a single-pill fixed-dose combination of valsartan and amlodipine.
Miura S; Saku K
J Int Med Res; 2012; 40(1):1-9. PubMed ID: 22429340
[TBL] [Abstract][Full Text] [Related]
10. ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients.
Volpe M; de la Sierra A; Kreutz R; Laurent S; Manolis AJ
High Blood Press Cardiovasc Prev; 2014 Jun; 21(2):137-47. PubMed ID: 24532183
[TBL] [Abstract][Full Text] [Related]
11. Single-pill combination of amlodipine and valsartan in the management of hypertension.
Flack JM; Hilkert R
Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937
[TBL] [Abstract][Full Text] [Related]
12. Olmesartan/amlodipine: a review of its use in the management of hypertension.
Kreutz R
Vasc Health Risk Manag; 2011; 7():183-92. PubMed ID: 21490944
[TBL] [Abstract][Full Text] [Related]
13. A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives.
Weir MR; Ferdinand KC; Flack JM; Jamerson KA; Daley W; Zelenkofske S
Hypertension; 2005 Sep; 46(3):508-13. PubMed ID: 16116046
[TBL] [Abstract][Full Text] [Related]
14. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
Chrysant SG
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study.
Allemann Y; Fraile B; Lambert M; Barbier M; Ferber P; Izzo JL
J Clin Hypertens (Greenwich); 2008 Mar; 10(3):185-94. PubMed ID: 18326958
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Julius S; Kjeldsen SE; Weber M; Brunner HR; Ekman S; Hansson L; Hua T; Laragh J; McInnes GT; Mitchell L; Plat F; Schork A; Smith B; Zanchetti A;
Lancet; 2004 Jun; 363(9426):2022-31. PubMed ID: 15207952
[TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.
Bramlage P; Fronk EM; Wolf WP; Smolnik R; Sutton G; Schmieder RE
Vasc Health Risk Manag; 2015; 11():1-8. PubMed ID: 25565857
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study.
Malacco E; Varì N; Capuano V; Spagnuolo V; Borgnino C; Palatini P;
Clin Ther; 2003 Nov; 25(11):2765-80. PubMed ID: 14693303
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice.
Bramlage P; Wolf WP; Stuhr T; Fronk EM; Erdlenbruch W; Ketelhut R; Schmieder RE
Vasc Health Risk Manag; 2010 Sep; 6():803-11. PubMed ID: 20859549
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients not adequately controlled with valsartan monotherapy.
Huang J; Sun NL; Hao YM; Zhu JR; Tu Y; Curt V; Zhang Y;
Clin Exp Hypertens; 2011; 33(3):179-86. PubMed ID: 21466389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]